Additional mRNA COVID-19 Vaccine for Moderately to Severely Immunocompromised People

During this COCA Call, presenters will discuss the current data on COVID-19 vaccines in immunocompromised people; the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and CDC’s guidance on additional COVID-19 doses in immunocompromised people.

This video can also be viewed at

Related Articles

Are COVID-19 Vaccines Free for Children?

Latino and Black parents were less likely than White parents to say they felt their child was “very safe” from COVID-19 when they were at school, according to a recent study.  How can you protect your children?   Vaccines are the best way to protect yourself and your children against the worst outcomes of the virus …
The post Are COVID-19 Vaccines Free for Children? appeared first on Salud America.

Are COVID-19 Vaccines Free for Adults?

We have come a long way in our fight against COVID-19, in large part thanks to vaccines that help us prevent serious illness and death.  But the virus has not gone away.  Fortunately, vaccines are available and free for adults, and they’re the best way to protect yourself and your familia against the worst outcomes …
The post Are COVID-19 Vaccines Free for Adults? appeared first on Salud America.

Do You Know the CDC’s New COVID-19 Vaccine Recommendations?

The CDC recently announced updated COVID-19 vaccination recommendations. The update allows people ages 65 and older or immunocompromised to get an additional updated bivalent vaccine dose at least four months after their initial bivalent dose. “If you’re in this group and have questions about getting an additional COVID-19 vaccine dose, you should consult your healthcare …
The post Do You Know the CDC’s New COVID-19 Vaccine Recommendations? appeared first on Salud America.

Moderna Launches First Ever HIV Vaccine Clinical Trial

Forty years after the virus was discovered, an HIV vaccine is finally in development. Moderna and the International AIDS Vaccine Initiative (IAVI) are launching the first clinical trial for an HIV vaccine. “The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be …
The post Moderna Launches First Ever HIV Vaccine Clinical Trial appeared first on Salud America.

Protect Your Family from RSV

With the winter season in full swing, it’s peak time for flu, COVID-19, and RSV.   Respiratory syncytial virus (RSV) is a respiratory virus that usually causes mild, cold-like symptoms.  Most people recover in a week or two. But RSV can be serious, especially for infants and older adults. Latino children also face a “significantly higher burden.”  …
The post Protect Your Family from RSV appeared first on Salud America.

Responses